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Nitrosopersulfide (SSNO-) targets soluble guanylyl
cyclase and induces vasodilation in vivo
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Background
Recent experimental evidence suggests that nitric oxide
(NO) and hydrogen sulfide signaling pathways are inti-
mately intertwined particularly in the vasculature, with
mutual attenuation or potentiation of biological
responses under control of the soluble guanylyl cyclase
(sGC) / phopshodiesterase (PDE) pathway. There is now
compelling evidence that part of the NO/sulfide cross
talk has a chemical foundation via the formation of S/N-
hybrid molecules including thionitrous acid (HSNO) and
nitrosopersulfde (SSNO-). The aim of this study was to
characterize the bioactive products of the interaction
between sulfide and NO metabolites targeting sGC that
may potentially regulate vasodilation.
Results
We found that the chemical interaction of sulfide with
NO or nitrosothiols leads to formation of S/N-hybrid
metabolites including SSNO- via intermediate formation
of HSNO. Contrary to a recent report in the literature
but consistent with the transient nature of HSNO, its
formation was not detectable by high-resolution mass
spectrometry under physiologically relevant conditions.
SSNO- is also formed in non-aqueous media by the
reaction of nitrite with oxidized sulfur species including
colloidal sulfur and polysulfides. SSNO- is stable in the
presence of high concentrations of thiols, release NO,
and activates sGC in RFL-6 cells in an NO-dependent
fashion. Moreover, SSNO- is a potent vasodilator in aor-
tic rings in vitro and lowers blood pressure in rats in
vivo. The presence of high concentrations of SOD or
thiols does not affect SSNO- mediated sGC activation,
while it potentiates and inhibits the effects of the
nitroxyl (HNO) donor Angeli’s salt, suggesting that
HNO release from SSNO- is not involved in sGC
activation.
Conclusion
The reaction between NO and sulfide leads to fomation
of S/N-hybrid molecules including SSNO-, releasing
NO, activating sGC and inducing vasodilation. SSNO- is
considerably more stable than HSNO at pH 7.4 and
thus a more likely biological mediator that can account
for the chemical cross-talk between NO and sulfide.
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